Abstract:Gain-of-function mutations of a gene result in new molecular function. Genetic studies show that mutations in a gene named as RNA binding motif 20 (RBM20) are associated with dilated cardiomyopathy (DCM). To test whether Rbm20 mutations are responsible for cardiac remodelling and potential underlying mechanisms, we selected two mutations (S637A and S639G) located in arginine/serine-rich domain of RBM20 and generated two knock-in mouse models ( Rbm20 S637A and Rbm20 S639G ) respectively. Both mouse lines were subjected to histological and anatomical analysis as well as cardiac function assessment with echocardiography. The results revealed that heterozygous (HT) and homozygous (HM) male and female mice from both lines displayed DCM phenotype with enlarged left ventricular (LV) chamber, thinner LV walls and reduced ejection fraction. Interestingly, we observed that Rbm20 S639G mice manifested more severe phenotype than that in Rbm20 S637A mice. Rbm20 S639G HM mice exhibited higher mortality rate (~50%) than that (~34%) in Rbm20 S637A HM mice at an early age (<100 days). Differentially expressed and spliced genes from RNA-seq data are involved in arrhythmia, cardiomyopathy, and sudden death based on Human Phenotype Ontology enrichment analysis (FDR≤0.05) in both lines. Immunofluorescent analysis in tissues and single cardiomyocytes respectively showed both mutations promote RBM20 nucleocytoplasmic trafficking and protein condensates, suggesting they are gain-of-function mutations, leading to high mortality rate at younger age. Both mutations also interrupted the alternative splicing of TTN and calcium handling genes. Force measurements and Ca 2+ transient evaluation of intact myocytes showed that the reduced cellular diastolic stiffness and impaired contractility in HT and HM mice. Studies suggested that phosphorylation of RS domain is critical for protein trafficking. We then performed mass spectrometry on the in vitro expressed RBM20 and identified phosphorylation on S637 and S639. Phosphomimetic assay showed that phosphorylation was not responsible for RBM20 trafficking and condensates. Together, we reported a new mechanism by which cardiac genetic mutations causes protein trafficking and aggregation in cardiac remodelling.

A Modifier Screen Identifies DNAJB6 As a Cardiomyopathy Susceptibility Gene.

Amendment history : Corrigendum ( April 2017 ) A modifier screen identifies DNAJB 6 as a cardiomyopathy susceptibility gene

Identification and Functional Prediction of Long Non-Coding RNAs in Dilated Cardiomyopathy by Bioinformatics Analysis

Abstract 13431: Gain-of-Function Mutations in RNA Binding Motif 20 Result in Cardiac Remodelling and Pathogenesis in Mice

1-Deoxynojirimycin Promotes Cardiac Function and Rescues Mitochondrial Cristae in Mitochondrial Hypertrophic Cardiomyopathy.

ZBTB17 Loss-of-function Mutation Contributes to Familial Dilated Cardiomyopathy

Identification of Target Genes and Transcription Factors in Mice with LMNA-Related Dilated Cardiomyopathy by Integrated Bioinformatic Analyses.

CASZ1 Loss-of-function Mutation Contributes to Familial Dilated Cardiomyopathy

A phenotype-based forward genetic screen identifies Dnajb6 as a sick sinus syndrome gene

Dissection of Z‐disc myopalladin gene network involved in the development of restrictive cardiomyopathy using system genetics approach

Next-generation sequencing identifies pathogenic and modifier mutations in a consanguineous Chinese family with hypertrophic cardiomyopathy

Genetic Dissection of Hypertrophic Cardiomyopathy with Myocardial RNA-Seq

Identification of BMP10 as a Novel Gene Contributing to Dilated Cardiomyopathy

Identification of KIAA0196 As a Novel Susceptibility Gene for Myofibril Structural Disorganization in Cardiac Development.

Mutations in CHMP4C Cause Dilated Cardiomyopathy Via Dysregulation of Autophagy

Identification and Genetic Analysis of Rare Variants in Myosin Family Genes in 412 Han Chinese Congenital Heart Disease Patients.

A personalized mRNA signature for predicting hypertrophic cardiomyopathy applying machine learning methods

VEZF1 Loss-of-function Mutation Underlying Familial Dilated Cardiomyopathy.

Detection and functional characterization of a novel <i>MEF2A</i> variation responsible for familial dilated cardiomyopathy

A Novel Tbx20 Loss-Of-Function Mutation Contributes to Adult-Onset Dilated Cardiomyopathy or Congenital Atrial Septal Defect

Multiplexed Functional Assessments of MYH7 Variants in Human Cardiomyocytes